Intellectual property issues and regimes and the South : the case of India

dc.contributor.authorJain, Dipika
dc.date.accessioned2011-02-15T14:49:08Z
dc.date.available2011-02-15T14:49:08Z
dc.date.issued2008
dc.description.abstractThis report traces the background to India’s pharmaceutical sector and the growth of the industry, including trade agreements, patent law and intellectual property rights in terms of access to medicine and essential drugs. The Indian generic manufacturing industry is in a phase of transition. The paper advocates for development of a new strategy for ensuring access to treatment in the post-TRIPS world. The Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement itself contains flexible mechanisms for balancing access to treatment with the preservation of intellectual property rights, such as compulsory licensing, parallel importation and patent opposition procedures.en
dc.format.extent1 digital file (66 p. in various pagings : ill.)en
dc.format.mimetypeapplication/pdf
dc.identifier.urihttp://hdl.handle.net/10625/45710
dc.language.isoen
dc.publisherIDRC, Ottawa, ON, CAen
dc.subjectESSENTIAL DRUGSen
dc.subjectINTELLECTUAL PROPERTY RIGHTSen
dc.subjectPATENT LAWen
dc.subjectPHARMACEUTICAL INDUSTRYen
dc.subjectLEGAL FRAMEWORKen
dc.subjectMEDICINESen
dc.subjectWTOen
dc.subjectTRADE AGREEMENTSen
dc.subjectINDIAen
dc.subjectSOUTH ASIAen
dc.titleIntellectual property issues and regimes and the South : the case of Indiaen
dc.title.alternativeResearch technical reporten
dc.typeIDRC Final Reporten
idrc.copyright.holderIDRC
idrc.copyright.oapermissionsourceIDRC is copyright holderen
idrc.dspace.accessOpen Accessen
idrc.project.componentnumber104655034
idrc.project.number104655
idrc.project.titleIDRC Corporate Awards 2007-2008en
idrc.rims.adhocgroupIDRC DOCUMENTen
idrc.rims.adhocgroupIDRC SUPPORTEDen

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
132169.pdf
Size:
583.96 KB
Format:
Adobe Portable Document Format
Description: